ghk-cu peptide skin benefits mechanism GHK-Cu Peptide Therapy for Radiant

A randomized double-blind placebo-controlled study of the long-term efficacy and safety of topiramate in the treatment of obese subjects

The crossover study (Parsons et al., 2012) reported that at 12 hours after a single instillation, 50% of patients reported a successful response to the active instillation with a 42% reduction in pain but only 13% reported a successful response to the placebo instillation accompanied by a 21% reduction in pain

GHK-Cu has more extensive human clinical research, particularly in dermatological applications

Research peptides are short chains of amino acids that are manufactured for laboratory and scientific research purposes only